Literature DB >> 20033478

RANKL and OPG mRNA level after non-surgical periodontal treatment.

Xanthippi E Dereka1, Cleopatra E Markopoulou, Galinos Fanourakis, Sofia Tseleni-Balafouta, Ioannis A Vrotsos.   

Abstract

Recent research evidence shows that the receptor activator of nuclear factor-kappa B ligand (RANKL) and osteoprotegerin (OPG) play an important role in osteoclastogenesis and the inflammatory bone loss during periodontitis. Bone remodeling process is dependent on the balance of these two proteins while a high ratio of RANKL/OPG characterizes the increased osteolytic process and it has been reported in inflammatory diseases including the periodontal disease. The purpose of this study was to determine the OPG and RANKL mRNA levels in periodontal tissues derived from patients with advanced chronic periodontitis after non-surgical periodontal therapy (SRP) and to compare the RANKL/OPG ration with that in healthy persons. Gingival biopsies were obtained from subjects with clinically healthy periodontium (H) (N = 11) and patients with advanced chronic periodontitis (CP) (N = 14). Total RNA was isolated from the gingival samples and 1 microg RNA was reverse transcribed to cDNA, followed by polymerase chain reaction (PCR) using specific primers for OPG and RANKL. The efficiency of reverse transcription was verified by the amplification of the GAPDH gene. The intensity of RT-PCR products was analyzed by a densitometer and was normalized to the intensity of the band for the housekeeping gene GAPDH. Immunohistochemical evaluation of the RANKL and OPG expression was also performed. The expression of RANKL as well as of OPG was reduced in CP specimens in comparison to that of healthy persons in a statistical significant way. However, the RANKL/OPG ratio showed to be slightly elevated in CP compared to H specimens but this finding was not of statistical significance. The immunohistochemical analysis revealed a non-uniform expression pattern for both proteins. Although further investigation is needed to identify the specific role of RANKL and OPG protein in periodontitis progression, our data after SRP might indicate the possible involvement of these proteins in the activation of pathways, which regulate the repair of the periodontal tissues.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20033478     DOI: 10.1007/s10753-009-9174-7

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  24 in total

1.  The cytolethal distending toxin induces receptor activator of NF-kappaB ligand expression in human gingival fibroblasts and periodontal ligament cells.

Authors:  G N Belibasakis; A Johansson; Y Wang; C Chen; S Kalfas; U H Lerner
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

2.  Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection.

Authors:  Y T Teng; H Nguyen; X Gao; Y Y Kong; R M Gorczynski; B Singh; R P Ellen; J M Penninger
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

Review 3.  Mechanisms of alveolar bone destruction in periodontitis.

Authors:  Z Schwartz; J Goultschin; D D Dean; B D Boyan
Journal:  Periodontol 2000       Date:  1997-06       Impact factor: 7.589

4.  Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.

Authors:  D L Lacey; E Timms; H L Tan; M J Kelley; C R Dunstan; T Burgess; R Elliott; A Colombero; G Elliott; S Scully; H Hsu; J Sullivan; N Hawkins; E Davy; C Capparelli; A Eli; Y X Qian; S Kaufman; I Sarosi; V Shalhoub; G Senaldi; J Guo; J Delaney; W J Boyle
Journal:  Cell       Date:  1998-04-17       Impact factor: 41.582

5.  Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.

Authors:  W S Simonet; D L Lacey; C R Dunstan; M Kelley; M S Chang; R Lüthy; H Q Nguyen; S Wooden; L Bennett; T Boone; G Shimamoto; M DeRose; R Elliott; A Colombero; H L Tan; G Trail; J Sullivan; E Davy; N Bucay; L Renshaw-Gegg; T M Hughes; D Hill; W Pattison; P Campbell; S Sander; G Van; J Tarpley; P Derby; R Lee; W J Boyle
Journal:  Cell       Date:  1997-04-18       Impact factor: 41.582

6.  osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification.

Authors:  N Bucay; I Sarosi; C R Dunstan; S Morony; J Tarpley; C Capparelli; S Scully; H L Tan; W Xu; D L Lacey; W J Boyle; W S Simonet
Journal:  Genes Dev       Date:  1998-05-01       Impact factor: 11.361

7.  Identification of the osteoprotegerin/receptor activator of nuclear factor-kappa B ligand system in gingival crevicular fluid and tissue of patients with chronic periodontitis.

Authors:  H-K Lu; Y-L Chen; H-C Chang; C-L Li; M Y-P Kuo
Journal:  J Periodontal Res       Date:  2006-08       Impact factor: 4.419

8.  Matrix metalloproteinases, their physiological inhibitors and osteoclast factors are differentially regulated by the cytokine profile in human periodontal disease.

Authors:  Gustavo P Garlet; Walter Martins; Benedito A L Fonseca; Beatriz R Ferreira; João S Silva
Journal:  J Clin Periodontol       Date:  2004-08       Impact factor: 8.728

9.  RANKL upregulation associated with periodontitis and Porphyromonas gingivalis.

Authors:  Nawarat Wara-aswapati; Rudee Surarit; Anek Chayasadom; Jason A Boch; Waranuch Pitiphat
Journal:  J Periodontol       Date:  2007-06       Impact factor: 6.993

10.  Receptor activator NF kappaB ligand (RANKL) and osteoprotegerin (OPG) protein expression in periodontitis.

Authors:  Tania Crotti; Malcolm D Smith; Robert Hirsch; Steven Soukoulis; Helen Weedon; Maria Capone; Michael J Ahern; David Haynes
Journal:  J Periodontal Res       Date:  2003-08       Impact factor: 4.419

View more
  8 in total

1.  Deficiency of cathepsin K prevents inflammation and bone erosion in rheumatoid arthritis and periodontitis and reveals its shared osteoimmune role.

Authors:  Liang Hao; Guochun Zhu; Yun Lu; Min Wang; Joel Jules; Xuedong Zhou; Wei Chen
Journal:  FEBS Lett       Date:  2015-04-17       Impact factor: 4.124

2.  Effect of periodontal surgery on osteoprotegerin levels in gingival crevicular fluid, saliva, and gingival tissues of chronic periodontitis patients.

Authors:  Sandy H S Hassan; Mahmoud I El-Refai; Noha A Ghallab; Rehab Fawzy Kasem; Olfat G Shaker
Journal:  Dis Markers       Date:  2015-02-28       Impact factor: 3.434

3.  The effect of Phase 1 periodontal treatment on the salivary RANKL/OPG ratio in severe chronic periodontitis.

Authors:  Somaye Ansari Moghadam; Somaye Sarani; Ebrahim Alijani; Alireza Ansari Moghadam
Journal:  Clin Cosmet Investig Dent       Date:  2019-08-14

4.  The expression levels of MicroRNA-146a, RANKL and OPG after non-surgical periodontal treatment.

Authors:  Mandana Sattari; Ramezan Ali Taheri; Reza ArefNezhad; Hossein Motedayyen
Journal:  BMC Oral Health       Date:  2021-10-13       Impact factor: 2.757

5.  Comparative assessment of bone mineral density levels in type 2 diabetic subjects with or without chronic periodontitis: A cross-sectional study.

Authors:  Hira Ateeq; Afaf Zia; Qayyum Husain; Afshan Bey
Journal:  J Adv Periodontol Implant Dent       Date:  2021-06-09

6.  Gingival crevicularfluid osteoprotegerin levels in Indian population.

Authors:  Purnima Bandari; M V Ramachandra Prasad; Arun Maradi; A R Pradeep; A Mallika; Dileep Sharma
Journal:  Dent Res J (Isfahan)       Date:  2012-11

7.  Effects of IL-10 and glucose on expression of OPG and RANKL in human periodontal ligament fibroblasts.

Authors:  L Zhang; Y Ding; G Z Rao; D Miao
Journal:  Braz J Med Biol Res       Date:  2016-04-08       Impact factor: 2.590

8.  MMP-8, TRAP-5, and OPG Levels in GCF Diagnostic Potential to Discriminate between Healthy Patients', Mild and Severe Periodontitis Sites.

Authors:  Marcela Hernández; Mauricio Baeza; Johanna Contreras; Timo Sorsa; Taina Tervahartiala; Macarena Valdés; Alejandra Chaparro; Patricia Hernández-Ríos
Journal:  Biomolecules       Date:  2020-10-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.